Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-arginine Supplementation in Heart Transplant Recipients
NCT00213915Phase 4Completed
- Sponsor
- Strasbourg University Hospital
- Start
- Feb 2004
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of arginine in heart transplantation, sponsored by Strasbourg University Hospital. Primary endpoints: Maximal exercise capacity at 6 weeks, Sub maximal exercise capacity at 6 weeks and 1 more. Started Feb 2004; status: completed.
02
Drugs
arginine
03
Conditions
heart transplantation
Beyond the preview
Go deeper on NCT00213915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00213915.